Cargando…
Study Design and Quality of Reporting of Randomized Controlled Trials of Chronic Idiopathic or Autoimmune Urticaria: Review
BACKGROUND: The recommended first-line therapy of chronic urticaria is second-generation antihistamines, but the modalities of treatment remains unclear. Numerous recommendations with heterogeneous conclusions have been published. We wondered whether such heterogeneous conclusions were linked to the...
Autores principales: | Le Fourn, Elodie, Giraudeau, Bruno, Chosidow, Olivier, Doutre, Marie-Sylvie, Lorette, Gérard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733774/ https://www.ncbi.nlm.nih.gov/pubmed/23940632 http://dx.doi.org/10.1371/journal.pone.0070717 |
Ejemplares similares
-
Chronic Idiopathic Urticaria and Thyroid Autoimmunity: Perplexing Association
por: Yadav, S, et al.
Publicado: (2013) -
Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial
por: Javaud, Nicolas, et al.
Publicado: (2019) -
Specific-class Skin Side-effects of Drugs Might Compromise Blinding in Randomized Controlled Trials
por: DO-PHAM, Giao, et al.
Publicado: (2023) -
OLOPATADINE IN CHRONIC IDIOPATHIC URTICARIA
por: Godse, Kiran V
Publicado: (2009) -
Discrepancies in the management of acquired cold contact urticaria: Results of a French-speaking urticaria experts questionnaire survey
por: Du-Thanh, Aurélie, et al.
Publicado: (2022)